Rea Diagnostics
PrivateLast Round
Grant
Sep 1, 2025
Total Funding Raised
$530,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Rea Diagnostics is a medtech company that develops non-invasive, at-home diagnostic tests for monitoring preterm birth risk in pregnant women.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rea Diagnostics Comparables
Compare Rea Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pregnolia AG | 79% | |
| MOMM Diagnostics | 73% | |
| Innitius | 70% |
Rea Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 1, 2025 | ||||
| Debt | Jan 22, 2024 | ||||
| Grant | Oct 29, 2020 | ||||
| Grant | Oct 1, 2019 | ||||
| Grant | Oct 1, 2019 | ||||
Convertible Debt | Aug 29, 2019 |
Key People
Founding team and executive leadership
Rea Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gebert Rüf Stiftung | Grant |
| Foundation for Technological Innovation | Debt, Grant |
| Knowledge Transfer UNIL CHUV | Grant |
| Innosuisse | Grant |
| EPFL Startup Launchpad | Grant |
| Venture Kick | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 197% MoM, reaching 4.4K.
- Jul 26, 2026
Monthly visitors increased 145% MoM.
Rea Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rea Diagnostics's valuation, stock price, and market status.
Is Rea Diagnostics a public or private company?
Rea Diagnostics is a private company.
What is the current stock price of Rea Diagnostics?
Rea Diagnostics is a private company with no public stock price. Caplight tracks Rea Diagnostics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Rea Diagnostics worth (valuation)?
Valuation information for Rea Diagnostics is not publicly available.
Can I buy Rea Diagnostics stock?
Rea Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Rea Diagnostics's last funding round?
Rea Diagnostics's most recent funding round was Grant on September 1, 2025.
Who are the main investors in Rea Diagnostics?
Key investors in Rea Diagnostics include Gebert Rüf Stiftung, Foundation for Technological Innovation, Knowledge Transfer UNIL CHUV, Innosuisse, EPFL Startup Launchpad.
Will Rea Diagnostics IPO soon?
No public IPO plans have been announced for Rea Diagnostics.
How can I track Rea Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rea Diagnostics's secondary market activity and sign up for updates.